ALPINE IMMUNE SCIENCES, INC. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Alpine Immune Sciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Alpine Immune Sciences, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$22.7M, a 45.6% decline year-over-year.
  • Alpine Immune Sciences, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$51.4M, a 22.5% increase year-over-year.
  • Alpine Immune Sciences, Inc. annual Operating Income (Loss) for 2023 was -$44.3M, a 23.9% increase from 2022.
  • Alpine Immune Sciences, Inc. annual Operating Income (Loss) for 2022 was -$58.1M, a 16.6% decline from 2021.
  • Alpine Immune Sciences, Inc. annual Operating Income (Loss) for 2021 was -$49.9M, a 73.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$44.3M +$13.9M +23.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 -$58.1M -$8.29M -16.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 -$49.9M -$21.1M -73.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-20
2020 -$28.7M +$14.8M +34% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 -$43.6M -$5.74M -15.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
2018 -$37.8M -$22.9M -153% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
2017 -$15M -$13.8M -1160% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-30
2016 -$1.19M -$817K -220% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 -$371K +$14.1M +97.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-28
2014 -$14.5M +$790K +5.17% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-13
2013 -$15.3M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.